Home - Products - Others - Other Targets - N-(4-fluorophenyl)benzo[d]thiazol-2-amine

N-(4-fluorophenyl)benzo[d]thiazol-2-amine

CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )

Catalog No. M28897 CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
2MG 29 In Stock
5MG 48 In Stock
10MG 79 In Stock
25MG 166 In Stock
50MG 230 In Stock
100MG 334 In Stock
200MG 455 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CYP17
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    348-45-8
  • Formula Weight
    244.29
  • Molecular Formula
    C13H9FN2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (511.69 mM)
  • SMILES
    Fc1ccc(Nc2nc3ccccc3s2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
molnova catalog
related products
  • (Tyr1)-TRAP-7

    YFLLRNP is a biological active peptide. (a partial agonist of PAR-1. YFLLRNP selectively active G12/13 signaling pathway without activating Gq or Gi pathways at low concentrations. YFLLRNP (60 μM))

  • Chiniofon

    Chiniofon, a halogenated 8-hydroxyquinoline, is used as an antiamebic drug. This type of anti-amebic drug exerts an anti-amebic effect by inhibiting intestinal commensal bacteria and affects amoebic dysentery, but has no effect on extra-intestinal amoebic parasites.

  • MSC2504877

    MSC2504877 is an inhibitor of tankyrase and enhances the effects of clinical CDK4/6 inhibitors. MSC2504877 suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb.